PMC:7435837 / 16810-16985
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T193","span":{"begin":10,"end":13},"obj":"Body_part"},{"id":"T194","span":{"begin":15,"end":30},"obj":"Body_part"}],"attributes":[{"id":"A193","pred":"fma_id","subj":"T193","obj":"http://purl.org/sig/ont/fma/fma63011"},{"id":"A194","pred":"fma_id","subj":"T194","obj":"http://purl.org/sig/ont/fma/fma63023"}],"text":"prominent GAG, heparan sulfate introduces the discussion on layer-by-layer (LbL) nanocoating.\n\n5. What Can LbL Nanocoating Contribute to the Prevention of Infectious Disease?\n"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T36","span":{"begin":155,"end":165},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"prominent GAG, heparan sulfate introduces the discussion on layer-by-layer (LbL) nanocoating.\n\n5. What Can LbL Nanocoating Contribute to the Prevention of Infectious Disease?\n"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T217","span":{"begin":10,"end":13},"obj":"Chemical"},{"id":"T219","span":{"begin":15,"end":30},"obj":"Chemical"},{"id":"T220","span":{"begin":15,"end":22},"obj":"Chemical"},{"id":"T221","span":{"begin":23,"end":30},"obj":"Chemical"}],"attributes":[{"id":"A217","pred":"chebi_id","subj":"T217","obj":"http://purl.obolibrary.org/obo/CHEBI_143889"},{"id":"A218","pred":"chebi_id","subj":"T217","obj":"http://purl.obolibrary.org/obo/CHEBI_18085"},{"id":"A219","pred":"chebi_id","subj":"T219","obj":"http://purl.obolibrary.org/obo/CHEBI_28815"},{"id":"A220","pred":"chebi_id","subj":"T220","obj":"http://purl.obolibrary.org/obo/CHEBI_24500"},{"id":"A221","pred":"chebi_id","subj":"T221","obj":"http://purl.obolibrary.org/obo/CHEBI_16189"}],"text":"prominent GAG, heparan sulfate introduces the discussion on layer-by-layer (LbL) nanocoating.\n\n5. What Can LbL Nanocoating Contribute to the Prevention of Infectious Disease?\n"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"408","span":{"begin":10,"end":13},"obj":"Chemical"},{"id":"409","span":{"begin":15,"end":30},"obj":"Chemical"},{"id":"411","span":{"begin":155,"end":173},"obj":"Disease"}],"attributes":[{"id":"A408","pred":"tao:has_database_id","subj":"408","obj":"MESH:D006025"},{"id":"A409","pred":"tao:has_database_id","subj":"409","obj":"MESH:D006497"},{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"prominent GAG, heparan sulfate introduces the discussion on layer-by-layer (LbL) nanocoating.\n\n5. What Can LbL Nanocoating Contribute to the Prevention of Infectious Disease?\n"}
LitCovid-PD-GlycoEpitope
{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T8","span":{"begin":15,"end":30},"obj":"GlycoEpitope"}],"attributes":[{"id":"A8","pred":"glyco_epitope_db_id","subj":"T8","obj":"http://www.glycoepitope.jp/epitopes/EP0086"}],"text":"prominent GAG, heparan sulfate introduces the discussion on layer-by-layer (LbL) nanocoating.\n\n5. What Can LbL Nanocoating Contribute to the Prevention of Infectious Disease?\n"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T123","span":{"begin":95,"end":97},"obj":"Sentence"},{"id":"T124","span":{"begin":98,"end":174},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"prominent GAG, heparan sulfate introduces the discussion on layer-by-layer (LbL) nanocoating.\n\n5. What Can LbL Nanocoating Contribute to the Prevention of Infectious Disease?\n"}